DCF — KINGSBROOK JEWISH MEDICAL CENTER
Enterprise Value: $-167.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-167.6M
Enterprise Value
$-56.0M
PV of Cash Flows
$-111.5M
PV of Terminal Value
$-179.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $195.1M | $-8.8M | -4.0% | $-17.0M | $-15.5M |
| Year 2 | $201.0M | $-7.0M | -3.0% | $-15.5M | $-12.8M |
| Year 3 | $207.0M | $-5.2M | -2.0% | $-13.9M | $-10.5M |
| Year 4 | $213.2M | $-4.3M | -2.0% | $-13.3M | $-9.1M |
| Year 5 | $219.6M | $-3.8M | -2.0% | $-13.1M | $-8.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-167.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$189.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999762469994
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5